Hey Bottle,
Not quite correct. The comparable quarter (to current) had revenue of $6.1M. This has nothing to do with the R&D rebate. The rebate boosts cash received in the quarter and minimises cash outflows, but is not part of the revenue figure. I have this quarter at a 30% increase on the previous, which is only a 9% increase on PCP. ( I think and hope that this may prove to be a conservative estimate).
My thoughts on AHZ, page-174
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.25 |
Change
-0.250(1.61%) |
Mkt cap ! $322.3M | |||
| Open | High | Low | Value | Volume |
| $15.50 | $15.50 | $14.80 | $140.4K | 9.315K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 297 | $15.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.25 | 1300 | 2 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |